M&As this week: Augment Investments, Recordati

Augment Investments has announced to acquire additional 10.032% stake in Pharmstandard OJSC, from Bristley Enterprises, to become a 79.8% stake holder in the company, upon the completion of the transaction.

Free Report

How attractive are current investment opportunities in Europe?

Europe has been identified as one of the most favorable regions for investors, seeing high investment activity in the past year. Most of these investments have been through Debt Offering, valued at close to $700 billion. The region has provided attractive investments in a diverse set of companies. Companies who tend to major themes such Digital Media, Cloud, Artificial Intelligence, E-commerce, and Big Data are recording the highest number of deals, with Digital Media recording close to 2,000 deals. However, GlobalData’s whitepaper offers a full view of the market, analyzing less successful or attractive points of investment as well, examining statistics on Equity Offering investments and PE/VC deals. Understand how government agencies for economies around the world use GlobalData Explorer to:

Track the M&A and Capital Raising volumes into their target market
Identify the top sectors in the target market attracting the investments
For any investment segment, identify the top Investors inside and outside the target economy that are already investing in the Segment
Assess and showcase the growth potential for various Industries in the target economy

Don’t miss out on key market insights that can help optimize your next investment – read the report now.

By GlobalData

By downloading this case study, you acknowledge that GlobalData may share your information with GlobalData and that your personal data will be used as described in their Privacy Policy

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to the transaction, Augment will hold 15.2m global depository receipts (GDS) of Pharmstandard.

Pharmaceutical company Recordati S.p.A has invested $144.6m to acquire 100% share capital of Italchimici S.p.A.

The company expects that the acquisition will help expand its gastroenterology products, as well as strengthen its portfolio.

Free Report

How attractive are current investment opportunities in Europe?

Track the M&A and Capital Raising volumes into their target market
Identify the top sectors in the target market attracting the investments
For any investment segment, identify the top Investors inside and outside the target economy that are already investing in the Segment
Assess and showcase the growth potential for various Industries in the target economy

Don’t miss out on key market insights that can help optimize your next investment – read the report now.

By GlobalData

By downloading this case study, you acknowledge that GlobalData may share your information with GlobalData and that your personal data will be used as described in their Privacy Policy

Free Report

How attractive are current investment opportunities in Europe?

Free Report

How attractive are current investment opportunities in Europe?

admin

Recommended Reports

PharmSource - CDMO and CRO Outlook: Robust Market Conditions...

OpportunityAnalyzer: Acromegaly and Gigantism – Opportunity ...

DE-102 (Macular Edema and Macular Degeneration) - Forecast a...

Viviant/Combriza (Osteoporosis) - Forecast and Market Analys...

Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026

Companies Intelligence

Bristley Enterprises Limited

Augment SAS

Pharmstandard

Italchimici Spa

Recordati SpA